More than Skin Deep: Examining the Full Impact of Tardive Dyskinesia

This Master Class session is designed to help healthcare professionals better understand the spectrum of potential consequences beyond physical appearance for individuals with TD, including negative impacts on physical, cognitive, and psychosocial functioning. Participants will learn how to implement optimal assessment strategies for the detection and evaluation of TD and will be introduced to the VMAT-2 inhibitors approved for the condition. The session will also provide an in-depth evaluation of the practical differences between these novel treatments, equipping participants to make informed decisions about which therapy to prescribe in individual cases. By the end of the session, participants will have gained valuable knowledge and skills for providing effective care for patients with TD, improving outcomes and quality of life for this patient population.

Supported by independent educational grants from Neurocrine and Teva Pharmaceuticals.